1.41
price up icon11.02%   0.14
after-market Dopo l'orario di chiusura: 1.42 0.01 +0.71%
loading

Soligenix Inc Borsa (SNGX) Ultime notizie

pulisher
Nov 21, 2025

What insider purchases suggest about Soligenix Inc. (DOA0) stockPortfolio Value Summary & Accurate Intraday Trade Tips - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Will Soligenix Inc. (DOA) stock see valuation expansionJuly 2025 Momentum & Accurate Technical Buy Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

Why Soligenix Inc. stock attracts high net worth investorsTrade Entry Summary & Advanced Swing Trade Entry Plans - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Soligenix Inc. stock responds to policy changesMarket Trend Review & Accurate Trade Setup Notifications - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

What insider trading reveals about Soligenix Inc. stockTrade Entry Report & Risk Managed Investment Strategies - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Soligenix Inc. (DOA0) stock gain from lower interest ratesJuly 2025 Macro Moves & Reliable Price Breakout Signals - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Soligenix Inc. (DOA) stock keep high P E multiples2025 Pullback Review & Risk Controlled Daily Plans - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Soligenix Inc. stock a buy for dividend growth2025 Market Overview & Trade Opportunity Analysis Reports - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Soligenix Inc. (DOA) stock a buy for dividend portfoliosJuly 2025 Weekly Recap & Fast Entry High Yield Stock Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Soligenix Inc. (DOA0) stock profit from fiscal stimulus2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Can Soligenix Inc. (DOA) stock deliver strong annual returns2025 Market Outlook & Daily Profit Maximizing Trade Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Soligenix Inc. (DOA0) stock safe for risk averse investorsMarket Activity Summary & Safe Investment Capital Preservation Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Soligenix hits enrollment target for CTCL treatment interim analysis By Investing.com - Investing.com Nigeria

Nov 19, 2025
pulisher
Nov 19, 2025

Is Soligenix Inc. (DOA0) stock cheap vs fundamentalsJuly 2025 Intraday Action & AI Enhanced Execution Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Soligenix (NASDAQ: SNGX) Completes Enrollment for Interim Analysis in Phase 3 FLASH2 Study of HyBryte - Digital Journal

Nov 19, 2025
pulisher
Nov 19, 2025

Is Soligenix Inc. trending in predictive chart modelsJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Soligenix Inc. (DOA0) stock attractive for growth fundsDollar Strength & AI Enhanced Execution Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Soligenix Inc. (DOA) stock extend growth storyMarket Movement Recap & Free Technical Pattern Based Buy Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Soligenix Completes Enrollment for Interim Analysis in Phase 3 FLASH2 Study of HyBryte for Cutaneous T-Cell Lymphoma – citybuzz - citybuzz

Nov 19, 2025
pulisher
Nov 19, 2025

Soligenix completes enrollment of patients for Phase 3 study evaluating HyBryte - TipRanks

Nov 19, 2025
pulisher
Nov 19, 2025

Soligenix Achieves Enrollment Milestone for Planned Interim Analysis in Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma - The Malaysian Reserve

Nov 19, 2025
pulisher
Nov 19, 2025

Soligenix achieves enrollment milestone for planned interim analysis in confirmatory phase 3 clinical trial of HyBryte for treatment of cutaneous T-cell lymphoma - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

Soligenix Achieves Enrollment Milestone for Planned Interim Analysis in Confirmatory Phase 3 Clinical Trial of Hybryte?? for the Treatment of Cutaneous T-Cell Lymphoma - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

Soligenix hits enrollment target for CTCL treatment interim analysis - Investing.com

Nov 19, 2025
pulisher
Nov 19, 2025

Soligenix (SNGX) Completes Key Enrollment for Phase 3 Study on C - GuruFocus

Nov 19, 2025
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):